Credit: Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
Stuart H Orkin, MD, Dana-Farber/Boston Children’s Cancer and Blood Disorders Center was recognized for the discovery of the molecular mechanism responsible for the switch from fetal to adult hemoglobin gene expression during human development and translating that knowledge into a novel treatment for the hemoglobin disorders -- sickle cell disease and beta-thalassemia.